RT
Ronen Twito at Xtl Biopharmaceuticals (TAE: XTL)
Developer of therapeutics for the treatment of multiple myeloma (MM), schizophrenia and hepatitis
ContactFirm
Xtl Biopharmaceuticals (TAE: XTL)
Location
Global
Investment Stage
Late Stage
Geographic Focus
Global
About Ronen Twito
Enriching content...
Similar Investors in Global
Contact Xtl Biopharmaceuticals (TAE: XTL)
Get in touch for investment criteria and partnership opportunities.
Contact